Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Vivace Therapeutics Appoints Craig Gibbs As CEO and Ellen Lubman As Chief Business and Strategy Officer

PRIVATEAug 26, 2026•about 6 hours ago

Position

Chief Executive Officer

Company

Vivace Therapeutics, Inc.

Craig Gibbs
San MateoBiotechnology

Description

Vivace Therapeutics, Inc. announced the appointment of Craig Gibbs, Ph.D., as President and Chief Executive Officer, and Ellen Lubman as Chief Business and Strategy Officer. These leadership changes aim to position the company for growth as it advances its lead candidate, VT3989, into a pivotal clinical trial.

Company Information

Company

Vivace Therapeutics, Inc.

Location

2929 CAMPUS DRIVE

San Mateo, California, United States

About

A venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

Don't miss Vivace Therapeutics, Inc.'s next move

Get an email the moment Vivace Therapeutics, Inc. changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Vivace Therapeutics, Inc.'s next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Vivace Therapeutics, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.